[RDHL] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -10.52%
YoY- 1.89%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 18,346 21,502 20,899 1,563 2,350 483 1 413.17%
PBT -11,711 -29,121 -16,047 -10,908 -11,118 -11,023 -6,552 10.15%
Tax 2,552 15 108 1,546 156 2,523 666 25.08%
NP -14,263 -29,121 -16,047 -10,908 -11,118 -11,023 -6,552 13.83%
Tax Rate - - - - - - - -
Total Cost 32,609 50,623 36,946 12,471 13,468 11,506 6,553 30.64%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -77.74 -135.43 -76.78 -697.89 -473.11 -2,282.19 -655,200.00 -77.81%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -10.04 -24.95 -17.95 -15.38 -20.84 -25.69 -20.58 -11.26%
EPS Diluted -10.04 -24.95 -17.95 -15.38 -20.84 -25.69 -20.55 -11.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.